These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33100927)

  • 1. The impact of operating flexibility on firms' performance during the COVID-19 outbreak: Evidence from China.
    Liu H; Yi X; Yin L
    Financ Res Lett; 2021 Jan; 38():101808. PubMed ID: 33100927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESG performance and stock prices: evidence from the COVID-19 outbreak in China.
    Li Z; Feng L; Pan Z; Sohail HM
    Humanit Soc Sci Commun; 2022; 9(1):242. PubMed ID: 35874283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extreme Temperatures and Firm-Level Stock Returns.
    He J; Ma X
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33669558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Product Market Competition and Firm Performance: Business Survival Through Innovation and Entrepreneurial Orientation Amid COVID-19 Financial Crisis.
    Liu Q; Qu X; Wang D; Abbas J; Mubeen R
    Front Psychol; 2021; 12():790923. PubMed ID: 35411208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brand equity and the Covid-19 stock market crash: Evidence from U.S. listed firms.
    Huang Y; Yang S; Zhu Q
    Financ Res Lett; 2021 Nov; 43():101941. PubMed ID: 36568952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 impact on firm investment-Evidence from Chinese publicly listed firms.
    Jiang J; Hou J; Wang C; Liu H
    J Asian Econ; 2021 Aug; 75():101320. PubMed ID: 36567767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stock market reaction to COVID-19: Evidence from U.S. Firms' International exposure.
    Au Yong HH; Laing E
    Int Rev Financ Anal; 2021 Jul; 76():101656. PubMed ID: 36569818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19, firm exposure, and firm value: A tale of two lockdowns.
    Ding H; Fan H; Lin S
    China Econ Rev; 2022 Feb; 71():101721. PubMed ID: 35058680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How geopolitical risk affect firms' internationalization performance: Evidence from China.
    Guo J
    Heliyon; 2024 May; 10(9):e30152. PubMed ID: 38694047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19, ESG investing, and the resilience of more sustainable stocks: Evidence from European firms.
    Cardillo G; Bendinelli E; Torluccio G
    Bus Strategy Environ; 2022 Jun; ():. PubMed ID: 35942337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of blockchain technology initiatives on firms' market value.
    Ali HS; Jia F; Lou Z; Xie J
    Financ Innov; 2023; 9(1):48. PubMed ID: 36741237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of energy consumption structure transformation on firms' total factor productivity: evidence from China.
    Zhang Z; Ma Y
    Environ Sci Pollut Res Int; 2023 Jul; 30(31):76950-76968. PubMed ID: 37249767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the COVID-19 pandemic: Evidence from the U.S. restaurant industry.
    Song HJ; Yeon J; Lee S
    Int J Hosp Manag; 2021 Jan; 92():102702. PubMed ID: 33024347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New evidence on COVID-19 and firm performance.
    Ren Z; Zhang X; Zhang Z
    Econ Anal Policy; 2021 Dec; 72():213-225. PubMed ID: 34934261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dataset for the analysis of stock price responses to African Swine Fever Outbreaks in China.
    Xiong T; Zhang W; Chen CT
    Data Brief; 2022 Dec; 45():108574. PubMed ID: 36131954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-speed rail and firms' environmental performance: empirical evidence from China.
    Wang Z; Huang W; Li K; Wei W; Liu Z
    Environ Sci Pollut Res Int; 2023 Apr; 30(19):55187-55199. PubMed ID: 36884167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus disease outbreak and supply chain disruption: Evidence from Taiwanese firms in China.
    Tang CH; Chin CY; Lee YH
    Res Int Bus Finance; 2021 Apr; 56():101355. PubMed ID: 33731971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Assessment on Continued Public Health Threats: Evidence from China's Stock Market.
    Gu J
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33096757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Firms' exposures on COVID-19 and stock price crash risk: Evidence from China.
    Kong X; Jin Y; Liu L; Xu J
    Financ Res Lett; 2023 Mar; 52():103562. PubMed ID: 36471778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corporate climate risk and stock market reaction to performance briefings in China.
    Wu N; Xiao W; Liu W; Zhang Z
    Environ Sci Pollut Res Int; 2022 Jul; 29(35):53801-53820. PubMed ID: 35290587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.